vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Third Coast Bancshares, Inc.（TCBX）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Third Coast Bancshares, Inc.的1.3倍（$75.5M vs $57.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 17.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Third Coast Bancshares Inc.是一家总部位于美国墨西哥湾沿岸地区的区域性金融控股公司，主要为得克萨斯州及周边区域的中小企业、个人消费者和社区客户提供商业与零售银行服务，覆盖存贷款、抵押贷款、财富管理等业务。
PBYI vs TCBX — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$57.7M
两年增速更快
PBYI
近两年复合增速
17.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $57.7M |
| 净利润 | — | $16.4M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 28.4% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | 20.5% |
| 每股收益（稀释后） | $0.26 | $0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITCBX
| Q1 26 | — | $57.7M | ||
| Q4 25 | $75.5M | $56.5M | ||
| Q3 25 | $54.5M | $54.5M | ||
| Q2 25 | $52.4M | $52.0M | ||
| Q1 25 | $46.0M | $45.9M | ||
| Q4 24 | $59.1M | $46.3M | ||
| Q3 24 | $80.5M | $42.9M | ||
| Q2 24 | $47.1M | $41.7M |
净利润PBYITCBX
| Q1 26 | — | $16.4M | ||
| Q4 25 | — | $17.9M | ||
| Q3 25 | $8.8M | $18.1M | ||
| Q2 25 | $5.9M | $16.7M | ||
| Q1 25 | $3.0M | $13.6M | ||
| Q4 24 | — | $13.7M | ||
| Q3 24 | $20.3M | $12.8M | ||
| Q2 24 | $-4.5M | $10.8M |
毛利率PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 38.1% | ||
| Q3 25 | 17.6% | 41.9% | ||
| Q2 25 | 12.7% | 40.5% | ||
| Q1 25 | 8.7% | 37.8% | ||
| Q4 24 | 22.6% | 38.7% | ||
| Q3 24 | 27.4% | 37.9% | ||
| Q2 24 | -4.6% | 34.1% |
净利率PBYITCBX
| Q1 26 | — | 28.4% | ||
| Q4 25 | — | 31.7% | ||
| Q3 25 | 16.2% | 33.1% | ||
| Q2 25 | 11.2% | 32.2% | ||
| Q1 25 | 6.5% | 29.6% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | 25.2% | 29.8% | ||
| Q2 24 | -9.6% | 25.9% |
每股收益（稀释后）PBYITCBX
| Q1 26 | — | $0.88 | ||
| Q4 25 | $0.26 | $1.02 | ||
| Q3 25 | $0.17 | $1.03 | ||
| Q2 25 | $0.12 | $0.96 | ||
| Q1 25 | $0.06 | $0.78 | ||
| Q4 24 | $0.40 | $0.80 | ||
| Q3 24 | $0.41 | $0.74 | ||
| Q2 24 | $-0.09 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $650.5M |
| 总资产 | $216.3M | $6.6B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $175.2M | ||
| Q3 25 | $94.4M | $116.4M | ||
| Q2 25 | $96.0M | $113.1M | ||
| Q1 25 | $93.2M | $219.0M | ||
| Q4 24 | $101.0M | $371.2M | ||
| Q3 24 | $96.7M | $258.2M | ||
| Q2 24 | $96.8M | $241.8M |
总债务PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYITCBX
| Q1 26 | — | $650.5M | ||
| Q4 25 | $130.3M | $531.0M | ||
| Q3 25 | $115.3M | $513.8M | ||
| Q2 25 | $104.7M | $496.1M | ||
| Q1 25 | $97.1M | $479.8M | ||
| Q4 24 | $92.1M | $460.7M | ||
| Q3 24 | $71.1M | $450.5M | ||
| Q2 24 | $48.5M | $435.0M |
总资产PBYITCBX
| Q1 26 | — | $6.6B | ||
| Q4 25 | $216.3M | $5.3B | ||
| Q3 25 | $202.9M | $5.1B | ||
| Q2 25 | $194.9M | $4.9B | ||
| Q1 25 | $196.2M | $4.9B | ||
| Q4 24 | $213.3M | $4.9B | ||
| Q3 24 | $220.7M | $4.6B | ||
| Q2 24 | $205.0M | $4.5B |
负债/权益比PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $50.8M | ||
| Q3 25 | $9.7M | $20.7M | ||
| Q2 25 | $14.1M | $13.9M | ||
| Q1 25 | $3.6M | $10.5M | ||
| Q4 24 | $15.6M | $35.1M | ||
| Q3 24 | $11.0M | $22.0M | ||
| Q2 24 | $1.0M | $7.3M |
自由现金流PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | $33.4M | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — |
自由现金流率PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | 72.1% | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — |
资本支出强度PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | 3.8% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
现金转化率PBYITCBX
| Q1 26 | — | — | ||
| Q4 25 | — | 2.84× | ||
| Q3 25 | 1.10× | 1.15× | ||
| Q2 25 | 2.41× | 0.83× | ||
| Q1 25 | 1.21× | 0.77× | ||
| Q4 24 | — | 2.56× | ||
| Q3 24 | 0.54× | 1.72× | ||
| Q2 24 | — | 0.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TCBX
| Net Interest Income | $53.6M | 93% |
| Noninterest Income | $4.0M | 7% |
